Literature DB >> 9291152

Gene expression of catecholamine synthesizing enzymes and beta adrenoceptor subtypes during rat embryogenesis.

M Fujinaga1, J C Scott.   

Abstract

Timed-pregnant Sprague-Dawley rats were killed between gestational day (GD) 8 and 10, and embryos were explanted and separated into developmental stages according to a modified Theiler's system. Total RNA from each stage was isolated and subjected to reverse transcription-polymerase chain reaction (RT-PCR) assays to examine gene expression of catecholamine synthesizing enzymes and three subtypes of beta adrenoceptors. Expression of these genes was detected at much earlier stages than previously reported, and each enzyme and receptor subtype showed a different pattern of gene expression. For example, mRNA for tyrosine hydroxylase, the rate-limiting enzyme for catecholamine synthesis, was detected as early as stage 10a, late GD 8, before the neural crest cells appear (stage 12, mid GD 10). This contradicts the common belief that catecholamines are produced only in the cells of sympathoadrenal lineage which originate from the neural crest cells and the cells of central nervous system. Results from the present study indicate that catecholamine synthesis is not limited to the cells of sympathoadrenal lineage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291152     DOI: 10.1016/s0304-3940(97)00511-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Cyclic AMP signaling functions as a bimodal switch in sympathoadrenal cell development in cultured primary neural crest cells.

Authors:  M L Bilodeau; T Boulineau; R L Hullinger; O M Andrisani
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism.

Authors:  Kingsley Osuala; Candice N Baker; Ha-Long Nguyen; Celines Martinez; David Weinshenker; Steven N Ebert
Journal:  Physiol Genomics       Date:  2012-08-21       Impact factor: 3.107

3.  Activation of β-adrenergic receptors is required for elevated α1A-adrenoreceptors expression and signaling in mesenchymal stromal cells.

Authors:  Pyotr A Tyurin-Kuzmin; Julia I Fadeeva; Margarita A Kanareikina; Natalia I Kalinina; Veronika Yu Sysoeva; Daniyar T Dyikanov; Dmitriy V Stambolsky; Vsevolod A Tkachuk
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

4.  β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells.

Authors:  Maura Calvani; Lorenzo Cavallini; Annalisa Tondo; Valentina Spinelli; Luisa Ricci; Amada Pasha; Gennaro Bruno; Daniela Buonvicino; Elisabetta Bigagli; Marina Vignoli; Francesca Bianchini; Laura Sartiani; Maura Lodovici; Roberto Semeraro; Filippo Fontani; Francesco De Logu; Massimo Dal Monte; Paola Chiarugi; Claudio Favre; Luca Filippi
Journal:  Oxid Med Cell Longev       Date:  2018-11-13       Impact factor: 6.543

5.  Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus.

Authors:  Alessandro Pini; Camilla Fazi; Patrizia Nardini; Maura Calvani; Sergio Fabbri; Alessandro Guerrini; Giulia Forni; Giancarlo La Marca; Arianna Carolina Rosa; Luca Filippi
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

Review 6.  β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.

Authors:  Luca Filippi; Alessandro Pini; Maurizio Cammalleri; Paola Bagnoli; Massimo Dal Monte
Journal:  Med Res Rev       Date:  2021-12-29       Impact factor: 12.388

7.  β3-Adrenoceptors as Putative Regulator of Immune Tolerance in Cancer and Pregnancy.

Authors:  Maura Calvani; Annalisa Dabraio; Angela Subbiani; Daniela Buonvicino; Veronica De Gregorio; Sara Ciullini Mannurita; Alessandro Pini; Patrizia Nardini; Claudio Favre; Luca Filippi
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.